Progestin induced depression in endometriosis

E Cansu Cevik; Erdem Çevik; Hugh S Taylor

doi:10.1016/j.fertnstert.2025.02.033

Progestin induced depression in endometriosis

E Cansu Cevik, Erdem Çevik, Hugh S Taylor

Fertility and sterility · 2025 · vol. 123(6) , pp. 1155 · doi:10.1016/j.fertnstert.2025.02.033 · PMID:40021037 · W4407947183

letter OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper investigates the link between progestin treatment and depression in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial 2016

References (4)

The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial via openalex
W4381033777 via openalex
W4406294732 via openalex
W6875345836 via openalex

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-27T00:31:44.234380+00:00

License: CC0 · commercial use OK

[1] The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial 2016